In 2006, the regulation of S1P and S1P1 signaling was suggested as a novel therapeutic target for RA based on findings of increased levels of sphingosine kinase 1, S1P, and S1P1 in RA synovium [15]. Here, S1PR1 is linked to rheumatoid arthritis.